Clinical profile, management and outcomes of patients with cardiogenic shock undergoing transfer between centers in

M Isabel Barrionuevo-Sánchez1, Albert Ariza-Solé1, Ana Viana-Tejedor2

  • 1Servicio de Cardiología, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Bioheart, Grup de Malalties Cardiovasculars, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.

Insights

Interhospital transfer for ST segment elevation myocardial infarction-related cardiogenic shock (STEMI-CS) is low but associated with better outcomes. Centers with higher STEMI-CS volume and cardiac intensive care units (CICU) improve survival.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Health Services Research

Background:

  • ST segment elevation myocardial infarction-related cardiogenic shock (STEMI-CS) is a critical condition with high mortality.
  • Interhospital transfer strategies for STEMI-CS patients are crucial for optimizing outcomes.
  • Understanding the impact of hospital structure on STEMI-CS management is essential.

Purpose of the Study:

  • To analyze the clinical profile, management, and prognosis of STEMI-CS patients requiring interhospital transfer.
  • To evaluate the prognostic impact of structural variables within treating centers on STEMI-CS outcomes.
  • To compare outcomes between patients managed at different types of revascularization-capable centers.

Main Methods:

  • Retrospective analysis of 4189 STEMI-CS patients from 2016-2020 treated at revascularization-capable centers.
  • Patients categorized into: (A) hospitals with interventional cardiology only, (B) hospitals with interventional cardiology and cardiac surgery, and (C) transferred to centers with both.
  • Association of STEMI-CS volume, cardiac intensive care unit (CICU) availability, and heart transplant services with hospital mortality analyzed.

Main Results:

  • Transferred patients (Group C) were younger, had higher cardiovascular risk, and received more revascularization and mechanical support.
  • Crude mortality was significantly lower in transferred patients (46.2%) compared to non-transferred groups (60.3% in Group A, 54.4% in Group B).
  • Higher STEMI-CS treatment volume and CICU availability were independently associated with lower hospital mortality (OR 0.75 and 0.80, respectively).

Conclusions:

  • The proportion of STEMI-CS transfers is low, but these patients experience better outcomes.
  • Transferred patients are younger and undergo more invasive interventions.
  • Higher STEMI-CS case volume and CICU availability at receiving centers are linked to reduced mortality, highlighting the importance of specialized care.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
788
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
12
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9